Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Weinstock

Showing results (51-60 of 172) with videos related to

Pageof 18
Sort By:
Cancer Genetics and Cytogenetics|July 13, 2010
The transposase domain protein Metnase/SETMAR suppresses chromosomal translocationsJustin Wray, Elizabeth A Williamson, Sean Chester, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 20, 2010
Assessing surge capacity for radiation victims with marrow toxicityMatthew S Davids, Cullen Case, Raymond Hornung, et al.
Scientific Reports|November 22, 2019
Identification of Circulating Serum Multi-MicroRNA Signatures in Human DLBCL ModelsAfshin Beheshti, Kristen Stevenson, Charles Vanderburg, et al.
Infection Control and Hospital Epidemiology|August 11, 2004
Postexposure prophylaxis against varicella-zoster virus infection among recipients of hematopoietic stem cell transplant: unresolved issuesDavid M Weinstock, Michael Boeckh, Farid Boulad, et al.
Disaster Medicine and Public Health Preparedness|March 16, 2011
Health care system planning for and response to a nuclear detonationJohn L Hick, David M Weinstock, C Norman Coleman, et al.
Blood|August 24, 2012
Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2Diederik van Bodegom, Jun Zhong, Nadja Kopp, et al.
Blood|August 21, 2012
BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemiaChristopher J Ott, Nadja Kopp, Liat Bird, et al.
Plos One|November 13, 2012
Next-generation cDNA screening for oncogene and resistance phenotypesNobuaki Shindoh, Akinori Yoda, Yuka Yoda, et al.
EMBO Molecular Medicine|March 8, 2017
Deletion of ribosomal protein genes is a common vulnerability in human cancer, especially in concert with <i>TP53</i> mutationsRam Ajore, David Raiser, Marie McConkey, et al.
Oncotarget|June 11, 2016
Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclonesThomas Melchardt, Clemens Hufnagl, David M Weinstock, et al.
Pageof 18

Showing results (51-60 of 172) with videos related to

Sort By:
Pageof 18
Cancer Genetics and Cytogenetics|July 13, 2010
The transposase domain protein Metnase/SETMAR suppresses chromosomal translocationsJustin Wray, Elizabeth A Williamson, Sean Chester, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 20, 2010
Assessing surge capacity for radiation victims with marrow toxicityMatthew S Davids, Cullen Case, Raymond Hornung, et al.
Scientific Reports|November 22, 2019
Identification of Circulating Serum Multi-MicroRNA Signatures in Human DLBCL ModelsAfshin Beheshti, Kristen Stevenson, Charles Vanderburg, et al.
Infection Control and Hospital Epidemiology|August 11, 2004
Postexposure prophylaxis against varicella-zoster virus infection among recipients of hematopoietic stem cell transplant: unresolved issuesDavid M Weinstock, Michael Boeckh, Farid Boulad, et al.
Disaster Medicine and Public Health Preparedness|March 16, 2011
Health care system planning for and response to a nuclear detonationJohn L Hick, David M Weinstock, C Norman Coleman, et al.
Blood|August 24, 2012
Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2Diederik van Bodegom, Jun Zhong, Nadja Kopp, et al.
Blood|August 21, 2012
BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemiaChristopher J Ott, Nadja Kopp, Liat Bird, et al.
Plos One|November 13, 2012
Next-generation cDNA screening for oncogene and resistance phenotypesNobuaki Shindoh, Akinori Yoda, Yuka Yoda, et al.
EMBO Molecular Medicine|March 8, 2017
Deletion of ribosomal protein genes is a common vulnerability in human cancer, especially in concert with <i>TP53</i> mutationsRam Ajore, David Raiser, Marie McConkey, et al.
Oncotarget|June 11, 2016
Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclonesThomas Melchardt, Clemens Hufnagl, David M Weinstock, et al.
Pageof 18